Glasgow company Talking Medicines raises £1.1m from investors including Tern in drive to scale up patient sentiment platform.
A GLASGOW-based firm, which describes itself as “the world’s first social intelligence company for the pharmaceutical industry”, has raised £1.1 million of funding to scale up its data technology platform for measuring patient sentiment.